Organ-Specific Endothelial Cell Differentiation and Impact of Microenvironmental Cues on Endothelial Heterogeneity

Abstract

Endothelial cells throughout the body are heterogeneous, and this is tightly linked to the specific functions of organs and tissues. Heterogeneity is already determined from development onwards and ranges from arterial/venous specification to microvascular fate determination in organ-specific differentiation. Acknowledging the different phenotypes of endothelial cells and the implications of this diversity is key for the development of more specialized tissue engineering and vascular repair approaches. However, although novel technologies in transcriptomics and proteomics are facilitating the unraveling of vascular bed-specific endothelial cell signatures, still much research is based on the use of insufficiently specialized endothelial cells. Endothelial cells are not only heterogeneous, but their specialized phenotypes are also dynamic and adapt to changes in their microenvironment. During the last decades, strong collaborations between molecular biology, mechanobiology, and computational disciplines have led to a better understanding of how endothelial cells are modulated by their mechanical and biochemical contexts. Yet, because of the use of insufficiently specialized endothelial cells, there is still a huge lack of knowledge in how tissue-specific biomechanical factors determine organ-specific phenotypes. With this review, we want to put the focus on how organ-specific endothelial cell signatures are determined from development onwards and conditioned by their microenvironments during adulthood. We discuss the latest research performed on endothelial cells, pointing out the important implications of mimicking tissue-specific biomechanical cues in culture.

Mapping Intrapatient Response Heterogeneity and Lesion-specific Relapse Dynamics in Metastatic Colorectal Cancer

“…Metastatic lesions with higher responses were typically found in the liver, spleen, LN, and lungs. These organs have discontinuous or fenestrated endothelial membranes, which may lead to higher drug exposure, potentially conferring high treatment responses 47,48 . In contrast, the organs bearing poorly-responding lesions are usually those with continuous endothelial membranes and thus more limited drug distribution, such as the muscle and brain/CNS [49][50][51][52] .…”

In Vitro Modeling of the Blood–Brain Barrier for the Study of Physiological Conditions and Alzheimer’s Disease

“…Compared to endothelial tissue located in other regions of the human body, the brain endothelium is characterized by a higher selectivity, one of the most important features of the BBB in brain protection [ 28 ]. The most relevant particularities of this highly specialized endothelium are the lack of fenestration, the reduced transcellular transport via minimal pinocytosis, and the complex intercellular connections [ 29 ]. Indeed, the almost absent paracellular diffusion is a result of the presence of tight junctions (TJs) and adherens junctions (AJs) that connect two neighboring BMECs [ 30 ].…”

Potential Immunologic and Integrative Methods to Enhance Vaccine Safety

“…Presenter cell modification in the clinical hypothesis above explains why there is a conflict with the conclusions of an in vitro study, showing that the spike protein does not share tissue homology with myocarditis-associated antigens [ 33 ]. Numerous studies have demonstrated a slight increase in myocardial reactions and myocarditis, post vaccination—especially in young men [ 34 , 35 ]—and antigen modification of cardiac endothelial presenter cells [ 36 ] would invalidate that conclusion, and furthermore suggest that such modification is key to the damage done by SARS-CoV-2 and its antigens. The latter article argues that the protective benefit of the vaccine is greater than the slight risk of damage.…”